Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
In other words, the price has increased by $0.00 from its previous closing price. On the day, 0.95 million shares were traded. ATXS stock price reached its highest trading level at $5.27 during the session, while it also had its lowest trading level at $5.055.
Ratios:
To gain a deeper understanding of ATXS’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.49 and its Current Ratio is at 17.49. In the meantime, Its Debt-to-Equity ratio is 0.02 whereas as Long-Term Debt/Eq ratio is at 0.01.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Cantor Fitzgerald on April 29, 2025, initiated with a Overweight rating and assigned the stock a target price of $47.
On January 31, 2025, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $26.
On July 29, 2024, TD Cowen started tracking the stock assigning a Buy rating and target price of $35.TD Cowen initiated its Buy rating on July 29, 2024, with a $35 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATXS now has a Market Capitalization of 291200448 and an Enterprise Value of 63745572.
Stock Price History:
The Beta on a monthly basis for ATXS is 0.45, which has changed by -0.45968586 over the last 52 weeks, in comparison to a change of 0.092895746 over the same period for the S&P500. Over the past 52 weeks, ATXS has reached a high of $12.92, while it has fallen to a 52-week low of $3.56. The 50-Day Moving Average of the stock is -7.66%, while the 200-Day Moving Average is calculated to be -43.06%.
Shares Statistics:
It appears that ATXS traded 333.97K shares on average per day over the past three months and 606810 shares per day over the past ten days. A total of 56.43M shares are outstanding, with a floating share count of 46.42M. Insiders hold about 17.75% of the company’s shares, while institutions hold 86.67% stake in the company. Shares short for ATXS as of 1744675200 were 3152273 with a Short Ratio of 9.44, compared to 1741910400 on 3192096. Therefore, it implies a Short% of Shares Outstanding of 3152273 and a Short% of Float of 5.8000002.
Dividends & Splits
Against a Trailing Annual Dividend Yield of 0.0
Earnings Estimates
Investors are eagerly awaiting the insights provided by 4 analysts currently analyzing and rating the stock of Astria Therapeutics Inc (ATXS).The consensus estimate for the next quarter is -$0.47, with high estimates of -$0.45 and low estimates of -$0.5.
Analysts are recommending an EPS of between -$1.79 and -$2.02 for the fiscal current year, implying an average EPS of -$1.93. EPS for the following year is -$1.97, with 5.0 analysts recommending between -$1.65 and -$2.36.
